» Articles » PMID: 1327684

HCV RNA and Antibody to HCV Core Protein in Japanese Patients with Chronic Liver Disease

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 1992 Oct 1
PMID 1327684
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated the prevalence of hepatitis C virus (HCV) RNA and antibody (anti-HCVcore) to the putative HCV core protein in Japanese patients with chronic liver disease. Sera were screened by solid-phase enzyme immunoassay with a recombinant HCV core protein and by the reverse transcription-polymerase chain reaction (RT-PCR) test which directly detects the HCV genome. Anti-HCV core was detected with high titers in 95% (69/73) of chronic non-A, non-B hepatitis, and 94% (65/69) of anti-HCVcore-positive patients had the genome. Anti-HCVcore was also found with lower titers in 24% (10/41) of chronic hepatitis B virus carriers, and three of them had the genome. Only one (3%) of the 35 patients negative for anti-HCVcore tested positive to RT-PCR. These findings indicate the overwhelming prevalence of HCV infection in Japanese patients with chronic non-A, non-B hepatitis and a close relationship between the presence of anti-HCVcore and chronic hepatitis C in this population.

Citing Articles

Hepatitis C: progress and problems.

Cuthbert J Clin Microbiol Rev. 1994; 7(4):505-32.

PMID: 7834603 PMC: 358339. DOI: 10.1128/CMR.7.4.505.

References
1.
Takehara T, Hayashi N, Mita E, Hagiwara H, Ueda K, Katayama K . Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: implications for hepatitis C virus replication in infected tissue. Hepatology. 1992; 15(3):387-90. DOI: 10.1002/hep.1840150305. View

2.
Takamizawa A, Mori C, FUKE I, Manabe S, Murakami S, Fujita J . Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991; 65(3):1105-13. PMC: 239876. DOI: 10.1128/JVI.65.3.1105-1113.1991. View

3.
Davis G, BALART L, Schiff E, Lindsay K, Bodenheimer Jr H, Perrillo R . Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med. 1989; 321(22):1501-6. DOI: 10.1056/NEJM198911303212203. View

4.
Di Bisceglie A, MARTIN P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J . Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med. 1989; 321(22):1506-10. DOI: 10.1056/NEJM198911303212204. View

5.
Hopf U, Moller B, Kuther D, Stemerowicz R, Lobeck H, Walter E . Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol. 1990; 10(1):69-76. DOI: 10.1016/0168-8278(90)90075-3. View